Cellular Biomedicine: 3Q Earnings Snapshot

November 6, 2018

CUPERTINO, Calif. (AP) _ Cellular Biomedicine Group Inc. (CBMG) on Tuesday reported a loss of $12.7 million in its third quarter.

On a per-share basis, the Cupertino, California-based company said it had a loss of 72 cents. Losses, adjusted for non-recurring costs, came to 56 cents per share.

The biotechnology company posted revenue of $70,400 in the period. Its adjusted revenue was $70,000.

Cellular Biomedicine shares have climbed 26 percent since the beginning of the year. The stock has risen 32 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CBMG at https://www.zacks.com/ap/CBMG

Update hourly